Team Go-Karting Event to Accelerate Osteosarcoma Research

Miles Hartz, who loved Go-Karting, passed away from Osteosarcoma in June 2023. In his honor, we invite you to RACE for HOPE and support better treatments for Osteosarcoma.

Race Details

SpeedSportz Racing Park

23050 Speed Street
New Caney, TX 77357
(State Hwy 242 at US 59/I-69)

The race is Enduro style, with two to four drivers per team.

The drivers will have one hour total to race (approximately 15 minutes of track time per driver).

Following the main race, drivers can RACE the LEGENDS, Bobby HIllin Jr. and Alan Rudolph, with the purchase of a Legends Race ticket

To race, you must be at least 16 years old and 60 inches tall, with valid driver’s license. Liability waivers are required to race.

Check In Time: 9 a.m.

Race Start: 10 a.m.

Legends Race Start: 11:30 a.m.

Reception and Trophy Presentation to Follow

Meet The Legends

Bobby Hillin, Jr, NASCAR Champion

Alan Rudolph, Professional Go-Kart Champion

Event Contacts

Vanessa Peterson, Development Manager with the OSI, is available to answer any questions about the sponsorship opportunities and benefits for this event. She can be reached at vpeterson@osinst.org.

Emily O’Neal, Development Assistant with the OSI, is coordinating the teams and drivers for this event. Please send the names and emails of your team of four drivers to Emily prior to the event. She can be reached at eoneal@osinst.org.

“Osteosarcoma is a rare form of bone cancer with no advances in survivorship in over 40 years. Miles was a sweet, sincere, kind, and loving son, brother, cousin, and grandchild. His loving and magical presence are profoundly missed. It is so important to us as a family to support the OSI as it pushes for better treatment options and a cure.”

 

 David and Ingrid Hartz

Our Event Committee

Amanda Clark Austin 

Debbie and Mark Green 

David and Jennifer Hammer 

David and Ingrid Hartz 

Kirk Kuykendall 

Vanessa Peterson (OSI)

Alan Rudolph (Speedsportz)

Amy and Carl Selesky

Scott and Elizabeth Shackhouls 

Mike and Sonia Woodfall 

Tom Young 

Osteosarcoma Statistics

bone icon

Osteosarcoma is the most common childhood bone cancer.

microscope icon

No new treatments have been approved for osteosarcoma patients in 40 years.

ribbon icon

1 in 3 children with osteosarcoma will not survive.

What We Do

Our Strategy

Globally estimated, there are over 26,000 new cases of osteosarcoma diagnosed each year, with 1,000 being diagnosed in the US, but treatment options haven’t advanced in 40 years. To find a cure for osteosarcoma, we have to collaborate, innovate, and translate around the most promising science.

Our Mission

The Osteosarcoma Institute’s mission is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.

Our Impact

Removing obstacles, funding advancements, accelerating progress, and raising awareness. The Osteosarcoma Institute funds breakthrough clinical trials and science to identify new treatments and, ultimately, a cure for osteosarcoma.

$2,901,411

to Translational Science

$1,000,000

to Clinical Trials

$900,000

to Correlative Science

$346,402

to Discretionary Grants

Our Partners

Help Us Create a Breakthrough in Osteosarcoma Treatment

The Osteosarcoma Institute’s mission is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.

Translate »